Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001596771-17-000025
Filing Date
2017-03-30
Accepted
2017-03-30 16:33:08
Documents
1
Effectiveness Date
2017-03-30
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 15687
  Complete submission text file 0001596771-17-000025.txt   16835
Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152 248-980-6538
Gemphire Therapeutics Inc. (Filer) CIK: 0001638287 (see all company filings)

EIN.: 472389984 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-283723 | Film No.: 17726195
SIC: 2834 Pharmaceutical Preparations